Visiongain has published a new report entitled Medical Device Contract Manufacturing Market Report 2024-2034: Forecasts by Product (IVD Devices, Diagnostic Imaging Devices, Cardiovascular Devices, Diabetes Care Devices, Endoscopy Devices, Ophthalmology Devices, Orthopedic Devices, Dental Devices, Others), by Class of Device (Class I Medical Device, Class II Medical Device, Class III Medical Device), by Service (Device Development and Manufacturing Services, Quality Management Services, Packaging and Assembly Services, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies.

The global medical device contract manufacturing market is estimated at US$85.9 billion in 2024 and is projected to grow at a CAGR of 9.7% during the forecast period 2024-2034.

Navigating Innovation and Cost Challenges in the Medical Device Industry

The medical device industry faces significant challenges in sustaining innovation while managing the rising costs associated with technological advancements. High innovation costs—stemming from expensive materials, complex manufacturing processes, and rigorous clinical trials—burden the development of new medical devices. Additionally, strict regulatory requirements necessitate extensive testing and data collection, often leading to higher device prices, which can limit patient accessibility, particularly in resource-constrained regions.

In this competitive landscape, new players are continually entering the medical device contract manufacturing market, while established companies vie for market share. This competition drives prices down as firms attempt to undercut one another, thereby exerting pressure on profit margins. Coupled with the increasing costs of materials, equipment, and labour, companies must navigate a delicate balance between maintaining profitability and offering competitive pricing.

Moreover, the consolidation within the dental industry, marked by larger dental laboratories with enhanced purchasing power, intensifies pricing pressures on smaller players. Fluctuations in government regulations and changes in insurance coverage can further impact reimbursement rates for dental procedures, requiring providers to adapt their pricing strategies accordingly. Thus, while innovation remains critical for advancement, the financial challenges associated with it necessitate strategic navigation for success in the market.

How will this Report Benefit you?

Visiongain’s 337-page report provides 125 tables and 168 charts/graphs. Our new study is suitable for anyone requiring commercial, in-depth analyses for the medical device contract manufacturing market, along with detailed segment analysis in the market. Our new study will help you evaluate the overall global and regional market for Medical Device Contract Manufacturing. Get financial analysis of the overall market and different segments including type, process, upstream, downstream, and company size and capture higher market share. We believe that there are strong opportunities in this fast-growing medical device contract manufacturing market. See how to use the existing and upcoming opportunities in this market to gain revenue benefits in the near future. Moreover, the report will help you to improve your strategic decision-making, allowing you to frame growth strategies, reinforce the analysis of other market players, and maximise the productivity of the company.

What are the Current Market Drivers?

Changing Regulatory Landscape Drives Demand for Regulatory Services from Medical Device Contract Manufacturers

The shifting regulatory framework in medical device contract manufacturing encompasses the various policies and standards that govern medical device production and distribution. This includes changes to quality standards, safety protocols, documentation requirements, and compliance procedures enforced by regulatory agencies like the FDA in the United States and the EMA in Europe. To comply with revised laws, contract manufacturers must modify their operations, technology, and quality assurance methods.

Contract manufacturers actively monitor regulatory changes in the manufacturing, technology, and quality management sectors to address these challenges. They possess specialised teams focused on medical device regulatory affairs, allowing for the prompt adaptation of manufacturing and development practices in accordance with regulatory changes. This proactive approach reduces the burden on medical device companies, decreasing the necessity for frequent alterations to their manufacturing processes or technologies in response to regulatory changes. Consequently, medical device companies are increasingly favouring the proficiency and flexibility provided by contract manufacturers to manoeuvre through this evolving regulatory landscape.

Technological and Engineering Expertise Provided by Medical Device Contract Manufacturers

Advancements in technology have brought about a revolution in the contract manufacturing industry, leading to greater efficiency, better customisability, and improved communication between manufacturers and customers. With the help of these advances, contract manufacturers can fulfil strict quality criteria and accelerate product delivery. In medical device contract manufacturing, numerous significant technological innovations have been implemented to enhance operations. The adoption of sustainable and environmentally friendly practices mitigates ecological impact, while digital competencies utilise software and technologies to confer a competitive edge in the marketplace. Moreover, strategies for adaptability and personalisation bolster supply chain resilience and address varied client requirements. Additive manufacturing facilitates the swift and economical creation of prototypes, thereby decreasing time to market. Moreover, cloud computing provides a solution that reduces IT expenses and improves secure accessibility for clients.

By proactively embracing these advanced technologies, contract manufacturers secure a substantial competitive advantage in their manufacturing operations. Conversely, medical device companies that opt for in-house production frequently encounter significant investment demands, potentially constraining their ability to pursue other strategic initiatives. As a result, medical device companies are increasingly outsourcing to enhance efficiency, flexibility, and access to specialised expertise.

Where are the Market Opportunities?

Rising Geriatric Population and Increasing Incidence of Related Diseases

The global healthcare landscape is undergoing significant transformation, driven by the rising geriatric population and the corresponding increase in age-related diseases. This demographic shift presents substantial opportunities for the medical device contract manufacturing market, which plays a crucial role in addressing the unique healthcare needs of older adults.

As the geriatric population expands, there is an increasing focus on their specific healthcare requirements, often encompassing chronic conditions such as cardiovascular diseases, diabetes, arthritis, and neurodegenerative disorders. The higher prevalence of age-related diseases creates an environment ripe for medical device manufacturers, particularly those specializing in contract manufacturing.

Significant Growth Potential in Emerging Markets for Medical Device Contract Manufacturing

There’s a growing emphasis on building strong healthcare infrastructures in emerging economies. This increases the need for cutting-edge medical treatments and novel diagnostic tools. Effective medical technology are becoming more and more necessary as people’s knowledge of health issues grows and the prevalence of chronic diseases rises.

Furthermore, collaborations between regional producers and well-known multinational corporations can promote knowledge and technology exchange, resulting in higher-quality products that meet international standards. These kinds of partnerships can help local producers become more capable of serving both domestic and foreign markets.

Additionally, there is a growing need for customised medical solutions due to the ongoing shift towards personalised treatment. Contract manufacturing can be utilised by emerging markets to manufacture personalised medical equipment that cater to individual patient requirements while maximising production expenses.

In conclusion, there is a great deal of room for expansion in the contract manufacture of medical devices in emerging nations due to the need for innovation, growing healthcare demands, and government backing. Businesses who make strategic investments in these markets stand to gain from both the chance to help improve healthcare outcomes in these areas and from a rapidly growing customer base.

Competitive Landscape

The major players operating in the medical device contract manufacturing market are Jabil Inc., Gerresheimer AG, Nordson Corporation, Teleflex Incorporated, Celestica Inc., Plexus Corp, SteriPack Group Ltd., Nortech Systems, Inc., Invetech Pty Ltd., Flextronics International, Ltd., Benchmark Electronics Inc., Integer Holdings Corporation, STRATEC SE, West Pharmaceutical Services, Inc., Nemera, Carclo plc, Kimball Electronics, TE Connectivity, Tecomet, Inc., and Sanmina Corporation. These major players operating in this market have adopted various strategies comprising M&A, investment in R&D, collaborations, partnerships, regional business expansion, and new product launch.

Recent Developments

• On 23rd September 2024, Integer Holdings Corporation, a leading medical device contract development and manufacturing organization (CDMO), announced the completion of its facility expansions in Ireland.
• On 6th November 2023, Jabil Inc. acquired Retronix, an innovative provider in the reclamation and refurbishment of electronic components.

Notes for Editors

If you are interested in a more detailed overview of this report, please send an e-mail to contactus@visiongain.com or call +44 207 336 6100.

About Visiongain

Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.